NORBAFLEX

This brand name is authorized in Nigeria.

Active ingredients

The drug NORBAFLEX contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII QTG126297Q - DICLOFENAC SODIUM
 

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
 
Read more about Diclofenac
2
UNII LAV5U5022Y - METHYL SALICYLATE
 

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.
 
Read more about Methyl salicylate
3
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
 
Read more about Menthol
4
Linseed oil
UNII 84XB4DV00W - LINSEED OIL

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100714 Gel NORBAFLEX GEL 30GM GEL 1.16%; 1%; 3%; 5% 1 X 30G 16 NF-PP-339167 NORBAFLEX GEL 30GM DICLOFENAC DIETHYLAMINE BP 1.16%W/W, METHYL SALICYLATE BP 1%W/W, VIRGIN LINSEED OIL BP 3%W/W, MENTHOL USP 5%W/W DICLOFENAC DIETHYLAMINE BP 1.16%W/W, METHYL SALICYLATE BP 1%W/W, VIRGIN LINSEED OIL BP 3%W/W, MENTHOL USP 5%W/W A4-100714 Drugs Imported Products 130 Over The Counter (OTC) 7/3/2023 NORBARC PHARMACEUTICAL LIMITED, NO. 7 ABEOKUTA STREET EBUTE META 7036535830 norbarcpharm@yahoo.com MARINE LIFE SCIENCES., PLOT NO.30 PHASE III (EXT) HPSIDC, BADDI DSTT. SOLAN (H.P) INDIA, India 31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M01AB55 Diclofenac, combinations M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB55

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-10071, A4-100714

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈